Raymond James analyst Alexander Sklar maintains Vertex (NASDAQ:VERX) with a Outperform and raises the price target from $19 to $22.
Craig-Hallum Downgrades Surgalign Holdings to Hold, Announces $1.5 Price Target
Craig-Hallum analyst Matt Hewitt downgrades Surgalign Holdings (NASDAQ:SRGA) from Buy to Hold and announces $1.5 price target.